tyrosine has been researched along with Li-Fraumeni Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donehower, LA; Hansen, MF; Hudson, E; Jeffers, M; Resau, JH; Rong, S; Strong, L; Tainsky, M; Tsarfaty, I; Vande Woude, GF | 1 |
1 other study(ies) available for tyrosine and Li-Fraumeni Syndrome
Article | Year |
---|---|
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.
Topics: 3T3 Cells; Animals; Base Sequence; Cell Transformation, Neoplastic; Fibrosarcoma; Gene Expression; Humans; Li-Fraumeni Syndrome; Mice; Mice, Nude; Molecular Sequence Data; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Sarcoma, Experimental; Tumor Suppressor Protein p53; Tyrosine | 1995 |